USA Researchers Awarded Grants

The U.S. Department of Defense recently awarded researchers at the University of South Alabama (USA) College of Medicine two grants totaling more than $1.07 million to study the replication of mitochondrial DNA (mtDNA). Dr. Mikhail Alexeyev, professor of physiology and cell biology at the college, is principal investigator of the studies. Natalya Kozhukhar, a research technologist, and Viktoriya Pastukh, a research assistant, are working with Alexeyev on the projects. The mitochondria’s main function is to produce energy for the cell. Mitochondrial diseases are a group of inherited genetic disorders that can cause a wide range of health concerns. To treat mitochondrial diseases, scientists first must understand how mtDNA makes copies of itself. Alexeyev’s lab has succeeded in generating human/mouse hybrid cells that maintained human mtDNA for more than a year. Although the approaches are different, the aim of both funded studies is similar: to find out why mouse non-hybrid cells do not replicate human mtDNA.

Read More

MMoA To Present “Gateway: From Graffiti To Gallery”

MMoA To Present “Gateway: From Graffiti To Gallery”

Jubilee Festival Application Deadline Nears

Jubilee Festival Application Deadline Nears

ACF Outreach Event Coming Up

ACF Outreach Event Coming Up

Mobile Bay 40 Under 40 Nominations Open Until August 31

Mobile Bay 40 Under 40 Nominations Open Until August 31

Lewis Earns Top Honors For Creative Work

Lewis Earns Top Honors For Creative Work

USA Health Videographer Wins Two Tellys

USA Health Videographer Wins Two Tellys

PRCA Mobile Chapter To Host Breakfast On Intellectual Property

PRCA Mobile Chapter To Host Breakfast On Intellectual Property

Wilkins Miller Named A 2026 Top 400 Firm

Wilkins Miller Named A 2026 Top 400 Firm

Vision Of Loxley APT Closes On Funding For Loxley Residential Project

Vision Of Loxley APT Closes On Funding For Loxley Residential Project

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.